Indication

Malignant glaucoma

Malignant glaucoma, also known as aqueous misdirection or ciliary block glaucoma, is a severe form of secondary angle-closure glaucoma affecting the ocular visual system. Read more about Malignant glaucoma

42 drugs 33 manufacturers

Advertisement

Drugs that treat it

Common Malignant glaucoma therapies.

Showing 19–27 of 42 drugs

ACETAZOLAMIDE

CARBONIC ANHYDRASE INHIBITORS·ABSENCE EPILEPSY·+8
AVPAK

ACETAZOLAMIDE

CARBONIC ANHYDRASE INHIBITORS·ABSENCE EPILEPSY·+8
TRUPHARMA, LLC.

ACETAZOLAMIDE

CARBONIC ANHYDRASE INHIBITORS·ABSENCE EPILEPSY·+8
A-S MEDICATION

ACETAZOLAMIDE

CARBONIC ANHYDRASE INHIBITORS·ABSENCE EPILEPSY·+8
CHARTWELL RX LL
Filter & compare in the drug finder →Opens the drug finder with Malignant glaucoma preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Malignant glaucoma.

Malignant glaucoma, also known as aqueous misdirection or ciliary block glaucoma, is a severe form of secondary angle-closure glaucoma affecting the ocular visual system.

It characteristically arises as a postoperative complication of incisional or laser intraocular surgery—most frequently in patients with pre-existing angle closure, hyperopia, or nanophthalmos—though it can occasionally develop spontaneously.

The condition is pathophysiologically driven by the posterior diversion of aqueous humor into or behind the vitreous body.

This misdirection generates elevated posterior segment pressure that pushes the lens-iris diaphragm anteriorly, producing hallmark uniform shallowing or flattening of both the central and peripheral anterior chambers alongside normal to severely elevated intraocular pressure despite a patent peripheral iridotomy.

Personalize your experience

Follow Malignant glaucoma and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it